ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks Silvr, I agree and as more drugs, meeting these needs come out, their business strategy will gain credibility and attract more investors.

When comparing the Dosage and Administration with competitors I believe the sales team which is looking for Rheumatology experience, will launch targeting the following. Competitors do not appear to have the 300 mg option in their dosage guidance. They only offer 200 mg or 400 mg, ANIP will give prescribers more flexibility in titration of drugs upward or downward.

Rheumatoid Arthritis in Adults:
Initial dosage: 400 mg to 600 mg daily
Chronic dosage: 200 mg, 300 mg or 400 mg once daily (or in two divided doses)

Systemic Lupus Erythematosus in Adults which is looking for Rheumatoid
200 mg, 300 mg or 400 mg once daily (or in two divided doses)